Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 5Prostatic Hyperplasia 2Neoplasms 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Dutasteride 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Oxygen 1Nitrous Oxide 1Finasteride 1Diclofenac 1Cystoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Prostatic Hyperplasia × Dutasteride × Clear all
NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting
100 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT00375765 2017-01-19

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

GlaxoSmithKline

Phase 4 Completed
40 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡